Your email has been successfully added to our mailing list.

×

JAZZ – jazz pharmaceuticals plc (US:NASDAQ)

DELAYED
<$
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
1D
5D
1M
3M
YTD
1Y
3Y
1 Day —— JAZZ SPY QQQ SPX
Date
Time
Symbol
Headline
Impact
5/7
07:29 am
jazz
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "buy" rating re-affirmed by analysts at Jefferies Financial Group Inc..
Low REPORT
4/21
07:42 am
jazz
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its price target raised by analysts at Cantor Fitzgerald from $185.00 to $198.00. They now have an "overweight" rating o
Low REPORT
4/20
08:18 am
jazz
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its price target raised by analysts at Stifel Nicolaus from $195.00 to $202.00. They now have a "buy" rating on the stoc
Low REPORT
4/14
08:25 am
jazz
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its price target raised by analysts at Stifel Nicolaus from $195.00 to $202.00. They now have a "buy" rating on the stoc
Low REPORT
4/1
08:02 am
jazz
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its price target raised by analysts at Morgan Stanley from $162.00 to $176.00. They now have an "equal weight" rating on
Low REPORT
3/25
07:11 am
jazz
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) was downgraded by analysts at TheStreet from a "b" rating to a "c+" rating.
Medium REPORT
3/18
06:50 am
jazz
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "outperform" rating re-affirmed by analysts at SVB Leerink LLC.
Low REPORT
3/17
10:21 am
jazz
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) was upgraded by analysts at Zacks Investment Research from a "strong sell" rating to a "hold" rating. They now have a $181.
Low REPORT